buprenorphinemethadoneautism spectrum disorderattention deficit/hyperactivity disorder
… exposure to buprenorphine versus methadone, further supporting buprenorphine as a safe treatment option for opioid use disorder during pregn…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 28 of 2459Tislelizumabdurvalumabatezolizumab
…l lung cancer (ES-SCLC) provides only modest survival benefits. Tislelizumab has been recently approved by the European Commission, but head…
SLErituximabBelimumabsystemic lupus erythematosuscyclophosphamideBLMbDMARD
…e but had a worse survival than BLM used as the first bDMARD in SLE patients.…
budesonideFluticasoneasthmabeclomethasonemometasoneFluticasone modestly increased URTI, while ciclesonide reduced it. Budesonidechronic obstructive pulmonary disease
…TI, between multiple ICS doses and oral candidiasis and between budesonide dose and cataract.Conclusions ICSs are correlated with the esca…
Melanoma-BMmelanomaUPMC Hillman Cancer Center Biostatistics FacilityUniversity of Colorado Human Immune Monitoring Shared Resource FacilityLUAD-BM
…ferating B and T-cells, suggesting potential effector function. Melanoma-BM LAs also had increased intratumoral CD8+T-cells, unlike LUAD-BM…
GBMGBM43Purdue Center for Cancer ResearchglioblastomaIndiana Clinical and Translational Sciences Institute
…is a promising step toward improving immunotherapy responses in GBM by restoring NK cell metabolic fitness in TME.Acknowledgements …
tezepelumabChronic rhinosinusitisWAYFINDERNCT05274815prednisoneCRSwNPCRSsevere asthmaCRSsNP
…hese data contribute to the growing evidence of the efficacy of tezepelumab in patients with CRS, including CRSwNP.…
cancerPD-L1xVδ2 bsTCEmelanomaRCC
…s might improve outcome for a broader spectrum of patients with cancer. Phosphoantigen-responsive Vγ9Vδ2-T cells are potent immune cel…
haemochromatosishemochromatosiscirrhosisvenesection
…developing cirrhosis, HCC and mortality. Alongside treatment of haemochromatosis, it is crucial for healthcare professionals to evaluate and act…
NHSARC HounslowHCVWL ODNChelWest
…The NHS England HCV Elimination Programme fostered partnerships between…
SeladelparNumeric Rating Scale5-D Itch Scale
…Seladelpar is a first-in-class delpar (selective PPAR-delta agonist) indic…